OTTAWA, Sept. 26, 2022 (GLOBE NEWSWIRE) — The Canadian Centre on Substance Use and Addiction (CCSA) welcomes the deliberate federal hashish overview and seems ahead to alternatives to contribute proof on public well being, public security and fairness. This proof relies on analysis by our consultants and with communities in line with CCSA’s legislated position to supply impartial, data-driven, third-party recommendation to assist governments, organizations and people make knowledgeable selections on problems with substance use and dependancy.
“We feel the review provides an important opportunity to ensure Canada is achieving the public health and safety objectives it set when legalizing cannabis. It will also help the public understand what has been learned and researched,” says CEO Dr. Alexander Caudarella.
On-Premise Cannabis Use: Public Health and Safety Considerations and Cannabis Legalization: 2021-2022 Observations are the most recent in CCSA’s suite of hashish assets. Others embrace a Is It OK to Use Cannabis Use During Pregnancy and Breastfeeding public consciousness poster and a Knowing Your Limits with Cannabis: A Practical Guide to Assessing Cannabis Use booklet, each of which focus on hurt discount strategies.
Christine LeBlanc, Communications Advisor